Biocept, Inc. Skyrocketed
Mon, Mar 20, 2023 at 07:11 PM
Biocept, Inc. (BIOC:NASDAQ) soared at $0.32, representing a gain of 35.8%. The stock got featured on our News Catalysts scanner on Wed, Mar 01, 2023 at 09:28 AM in the 'PRIVATE PLACEMENT' category. From Mon, Mar 06, 2023, the stock recorded 10.00% Up Days and 9.09% Green Days
The stock spiked on Fri, Jan 06, 2023 at $0.67 with a volume of 2M+.
About Biocept, Inc. (BIOC:NASDAQ)
Biocept Inc is an early commercial-stage molecular oncology diagnostics company. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA assays utilizing a standard blood sample.
Top 10 Gainers:
- Loyalty Ventures Inc. (LYLT:NASDAQ), 153.78%
- Gelesis Holdings Inc. (GLS:NYSE), 90.82%
- Lifecore Biomedical Inc Com (LFCR:NASDAQ), 85.63%
- Ambipar Emergency Response Class A (AMBI:NYSEMKT), 71.99%
- GeneDx Holdings Corp Cl A (WGS:NASDAQ), 41.3%
- InMed Pharmaceuticals Inc. (INM:NASDAQ), 38.39%
- Allarity Therapeutics Inc. (ALLR:NASDAQ), 37.05%
- Biocept, Inc. (BIOC:NASDAQ), 35.84%
- Boxed Inc. (BOXD:NYSE), 35.74%
- SRAX, Inc. (SRAX:NASDAQ), 33.33%